KSKatie Jane Sheehan

Katie Jane Sheehan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katie Jane Sheehan has a total of 289 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Temporal Trends in the Prevalence of Frailty in England From 2002 to 2022, With Forecasts to 2040: Longitudinal Secondary Analysis of a National Cohort Study

    by Dongfeng Tang, Katie Jane Sheehan, Simon Conroy, Aicha Goubar, Julie Whitney, Yanzhong Wang, Matthew D L O'COnnell

    Background: The increasing life expectancy provides an opportunity for healthy longevity, but frailty is a potential challenge. Existing studies of frailty prevalence in England are largely cross-sectional, use heterogeneous frailty definitions, and rarely break down population-level drivers or project future burden, limiting their use for health and social care planning. Objective: This study aimed to explore temporal trends of frailty prevalence and project scenario-based future prevalence up to 2040 for the community-dwelling population aged 50 years and older in England. Methods: Prevalence of frailty (measured using a frailty index) in the overall sample and subgroups of age, sex, educational level, and marital status from 2002 to 2022 was estimated among the community-dwelling population aged 50 years and older using 10 waves of nationally representative data from the English Longitudinal Study of Ageing (ELSA; n=6226 to 11,218 across waves). The number of individuals with frailty was also derived in each year. Joinpoint regression models were used to explore temporal trends of frailty prevalence. A linear probability regression model was performed using pooled data from 10 waves of the ELSA to explore driving factors and project future prevalence. Decomposition analysis was used to estimate the contribution of individual factors to the change in prevalence. Results: A statistically nonsignificant ( P =.61) increase of 2.3 percentage points from 15.5% (1738/11,218) in 2002 to 17.8% (1108/6226) in 2022 was observed, with the number of individuals with frailty growing from 2,560,122 to 3,791,038 among community-dwelling adults aged 50 years and older in England. Those with advanced age, who were female, had a lower educational level, and/or were single had a consistently higher prevalence of frailty. Opposing contributions netted to this overall change: improvements in sociodemographic conditions and educational attainment and healthier lifestyle behaviors offset 222.5%, 94.9%, and 51.6% of the observed increase, respectively. Under scenario-based projections, prevalence was estimated at 20.5% (95% CI 19.2%-21.9%) in 2040, corresponding to 5,213,689 people with frailty. Conclusions: Despite a modest increase in prevalence among the community-dwelling population aged 50 years and older, the substantial growth in the absolute number of individuals with frailty indicates a likely rise in future care demands. The study contributes a 20-year trend, decomposition, and forecast framework for community-dwelling older adults. Findings support prioritizing broader sociodemographic development alongside educational attainment and healthy lifestyles, with potential policy approaches including income and social protection, housing improvements, access to health care, and prevention. Key limitations include self-reported measures, exclusion of care home residents, and potential influence of unmeasured effects.

  • Top Cited Papers
    Open Access

    Development and Internal Validation of a Machine Learning Model for Predicting Long‐Term Opioid Therapy After Hip Fracture Surgery in Older, Opioid‐Naïve Adults

    by Yasmina Maria Tudorache, Simon Storgaard Jensen, Katie Jane Sheehan, Jan‐Erik Gjertsen, Alma Becic Pedersen

    Background: Long‐term opioid therapy (LTOT) after hip fracture surgery is a common postoperative complication associated with adverse outcomes, yet tools to identify at‐risk patients among opioid‐naïve older adults are lacking. This study aimed to develop and internally validate a parsimonious model to predict LTOT following hip fracture surgery. Methods: Using Danish nationwide registries, we identified 26,057 opioid‐naïve patients (≥ 65 years) undergoing hip fracture surgery (2010–2020) and analysed 29 predictors, covering demographics, comorbidities, medication, lifestyle, socioeconomics and surgical factors. LTOT was defined as redeeming ≥ 2 prescriptions between 31 and 365 days of surgery. Models were developed using four machine learning methods: logistic regression, backwards elimination, elastic net penalised logistic regression and random forest. Model performance was assessed using area under the receiver operating characteristic curve (AUC), calibration slope, intercept, Brier score and decision curve analysis. Results: LTOT was identified in 8095 (31.1%) patients. The backward elimination algorithm identified the best performing model, selecting 8 of 29 predictors and achieving an AUC of 0.68, calibration slope of 0.99, intercept of 0.02 and Brier score of 0.20. Predictors included age, marital status, preoperative non‐opioid pain medication, preoperative novel oral anticoagulants, fracture type, surgery delay, length of hospital stay and postoperative cumulated ambulation score at discharge. Conclusions: A prediction model was developed and validated for use at discharge to identify patients at risk of LTOT 1 year after hip fracture. The model may support risk stratification at discharge, but requires external validation and evaluation of clinical implementation before routine use. Significance Statement: This study presents the first internally validated prediction model for long‐term opioid use in opioid‐naïve older adults after hip fracture surgery. The model functions as a simple and interpretable risk stratification tool at discharge and has been incorporated in a freely available risk calculator. It addresses the lack of clinically applicable risk stratification tools in this frail population and highlights opportunities for more targeted postoperative pain management, although feasibility testing is required before clinical implementation.


  • Open Access

    Patients’ and carers’ perspectives on unrestricted weight-bearing and early mobilisation after hip fracture surgery in Saudi Arabia: a qualitative study

    by Ruqayyah Y. Turabi, Katie Jane Sheehan, Matthew D. L. O’cOnnell, Iskandar C. Mrad, David Wyatt

    This study explored how patients and carers experienced weight-bearing instructions and mobilisation timing following hip fracture surgery. It also examined their views on unrestricted weight-bearing and early mobilisation and perceived barriers to these practices. Semi-structured interviews were conducted with 25 participants (18 carers, 7 patients) from Saudi Arabia's healthcare systems. The data were analysed using inductive thematic analysis. Participants viewed unrestricted weight-bearing and early mobilisation as important when prescribed by clinicians, reflecting strong trust in professional judgement. However, their experiences showed inconsistency in clinical instructions and how these were understood and implemented. Implementation was shaped by clinical instructions, clarity of communication, perceived safety, and patients' physical capacity and psychological state. Concerns about falls were mostly reported by carers as barriers to mobilisation, although some patients also described fear shaped by past injuries, difficult recoveries, or uncertainty about undiagnosed complications. Carers played a key role in encouraging mobilisation, adapting instructions, and maintaining continuity of care when weight-bearing and mobilisation were challenging for patients. To support adherence to weight-bearing and mobilisation instructions, clinicians should provide timely, consistent prescriptions aligned with evidence-based guidance. Communication must be inclusive to support understanding, confidence, and autonomy among patients and carers.

  • Rehabilitation after pelvic fragility fracture in older adults: a scoping review

    by Carina Carter, Stefanny Guerra, Lenise Clothier, Sophie Barlow, Rostislav Axenciuc, Rhian Milton-Cole, Xavier L Griffin, Katie Jane Sheehan

    Introduction To synthesise the evidence available on components of reported rehabilitation interventions following pelvic fragility fracture in older adults and describe outcomes measured. Methods A scoping review reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis Scoping Review extension. A systematic search of Cochrane CENTRAL, Embase, MEDLINE, and PEDro for studies of rehabilitation among patients 60 years and older with non-pathological pelvic fragility fractures, published up to May 2024. Single case studies were excluded. Screening and study selection were completed in duplicate by four independent reviewers. One reviewer completed extraction with accuracy checked by a second reviewer. A narrative synthesis approach was employed with text and tables. Results A total of 17 studies reporting on rehabilitation after pelvic fragility fracture were identified. For 13 studies, descriptors were limited to mobilisation strategies, with 9 citing unrestricted mobilisation as the first prescription. Three studies reporting multicomponent, multidisciplinary (physiotherapy-led) rehabilitation interventions across inpatient and community settings, incorporating exercise, psychological components, and education/advice were identified. A total of 31 outcome domains were identified, with key domains including pain, mobility, activities of daily living, quality of life, and mortality. There was an absence of consensus on which patient reported outcome instruments to use to measure relevant domains. Conclusions There is overall limited evidence to guide rehabilitation for older adults following fragility fracture of the pelvis. A standardised approach to rehabilitation should be designed which improves outcomes which matter most to those people affected.


  • Open Access

    Association between early mobilization after hip fracture surgery and risk of long-term opioid therapy

    by Yasmina Maria Tudorache, Ina Trolle Andersen, Thomas J. Hjelholt, Morten Tange Kristensen, Katie J. Sheehan, Alma B. Pedersen

    Key summary points: Aim: To examine the association between early mobilization after hip fracture surgery and the risk of long-term opioid therapy at 1-year follow-up. Findings: Long-term opioid therapy is a common complication after hip fracture surgery. Mobilization within 24 h after surgery is associated with a lower risk of long-term opioid therapy compared to mobilization between 24 and 36 h. Message: Early mobilization is one of the key elements of the successful patient recovery for reducing risk of complications and mortality after hip fracture surgery. Purpose: Early mobilization after hip fracture operation is associated with better clinical outcomes, but its impact on long-term opioid therapy (LTOT) remains unclear. Methods: Using Danish population-based registries we included patients aged ≥ 65 who underwent surgery for a first-time hip fracture between 2016 and 2021 (n = 36,229). LTOT was defined as redeeming ≥ 2 prescriptions between 31 and 365 days of surgery. Using stabilized inverse probability of treatment (sIPT) weighing, we calculated risks and risk differences with 95% confidence intervals (CI) for opioid use balancing mobilization groups ≤ 24 h vs 24–36 h on measured confounders and taking death into consideration. Results: 67.3% of all patients were women and the median age was 82.6 years (75.8; 88.6). 75% of patients were mobilized ≤ 24 h of surgery, whereas 8% were mobilized between 24 and 36 h, 4.9% > 36 h, and 12.1% had missing data on mobilization. Patients mobilized ≤ 24 h and 24–36 h were similar in age, fracture type, and marital status, but those mobilized ≤ 24 h had fewer comorbidities, better pre-fracture mobility, and a higher social position. They also had a lower risk of LTOT (29.99%) compared to those mobilized 24–36 h (33.42%), with a weighted risk difference of 3.44% (95% CI 1.58–5.30). Conclusions: LTOT is common after hip fracture surgery. Mobilization ≤ 24 h after surgery is associated with a lower risk of LTOT compared to mobilization between 24 and 36 h. Early mobilization is one of the key elements of successful patient recovery for reducing complications and mortality after hip fracture surgery.


  • Open Access

    Fragility Fracture Network Position on Unrestricted Weight-Bearing After Hip Fracture Surgery

    by Ruqayyah Turabi, Frede Frihagen, Rhona McGlasson, David Wyatt, Alex Trompeter, Lauren Beaupre, Luiz Fernando Cocco, Matthew Costa, José Luis Dinamarca-Montecinos, Juan Carlos Viveros-García, et al.

    Objectives: This position paper from the Fragility Fracture Network (FFN) responds to the observed global variation in weight-bearing prescriptions after hip fracture surgery in older adults. Methods: The paper summarises current guidelines and evidence regarding unrestricted weight-bearing after hip fracture surgery. Results: The synthesis of available evidence supports the endorsement of unrestricted weight-bearing after surgery to enhance patient outcomes. Conclusion: The FFN endorses unrestricted weight-bearing and recommends healthcare professionals, institutions, and policymakers re-evaluate practices favouring limited or non-weight-bearing prescriptions and establish a standardised system for monitoring and auditing, with clear justification and documentation of any restrictions.


  • Non-surgical interventions for arthrofibrosis following knee joint replacement: A systematic review

    by Michelle C Hall, Benjamin Smith, Katie J Sheehan, Stefanny Guerra, Bushra Abdunour, Melanie Narayanasamy, Joanne Stocks, Fiona Moffatt, Catherine Sackley

    Objective: To evaluate the effectiveness of non-surgical interventions for knee stiffness or arthrofibrosis following knee replacement surgery. Data sources: Ovid MEDLINE, Ovid Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and Cumulative Index to Nursing and Allied Health Literature (CINAHL)were searched from database inception to October 2024. Review methods: All studies of non-surgical interventions (versus any/no comparator) for adults who developed knee stiffness or a diagnosis of arthrofibrosis following knee replacement were included. Selection, quality appraisal and extraction were completed in duplicate. Results were synthesised narratively. The risk of bias was assessed, and GRADE criteria were used to evaluate evidence quality. Results: Sixteen studies were included, comprising two randomised-controlled trials (n = 76), one non-randomised controlled trial (n = 35), seven cohort studies (n = 352) and six case studies (n = seven). Interventions varied widely including exercise, manual therapy, mechanical devices, and education. Improvements in knee range of movement were reported with some demonstrating functional gains >110° of knee flexion, but the evidence was of low quality. Limited reporting of intervention descriptions, patient-relevant outcomes including function and pain, and longer-term follow-up hindered comprehensive evaluation. Conclusion: The review highlights the heterogeneity of interventions, emphasising the need for standardised reporting. While some studies showed promise, the lack of control groups, small sample sizes, and varied follow-up durations limit conclusive findings. There is insufficient evidence to support any specific non-surgical interventions for arthrofibrosis post-arthroplasty. Further research should be a priority.


  • Open Access

    Interdisciplinary Oral Nutrition Support and Supplementation After Hip Fracture Surgery in Older Adult Inpatients: A Global Cross-Sectional Survey (ONS-STUDY)

    by Jack Bell, Ruqayyah Turabi, Sissel Urke Olsen, Katie Jane Sheehan, Ólöf Guðný Geirsdóttir

    Background: Malnutrition predicts poor outcomes following hip fracture, affecting patient recovery, healthcare performance, and costs. Evidence-based guidelines recommend multicomponent, interdisciplinary nutrition care to improve intake, reduce complications, and enhance outcomes. This study examines global variation in oral nutrition support for older (65+ years) hip fracture inpatients. Methods: A global survey was conducted as part of a broader program to improve interdisciplinary nutrition care. The protocol was based on evidence-based guidelines, reviewed by experts, and piloted for validity. Recruitment used snowball sampling to achieve diversity across income levels, countries, and healthcare roles. Results: The survey (July–September 2023) recruited 308 participants from 46 countries across five global regions. Respondents primarily worked in acute teaching (57.5%) and non-teaching (17.5%) hospitals, representing medical (48.4%), nursing (28.2%), and allied health (17.9%) roles. Findings revealed a global knowledge-to-practice gap in multicomponent nutrition care, across providing high-protein/energy food and fluids (median: “half the time”), post-operative provision of oral nutritional supplements (median: “half the time”) and continuation for one month with assessment (median: “not very often”), and nutritional education (median: “not very often”). Only 17.9% of respondents reported routine provision (“often” and “nearly always or always”) of high-protein/energy food, supplements, and education. Substantial regional variation showed Western Pacific respondents perceiving the lowest provision across multicomponent processes. Interdisciplinary, multicomponent interventions were seen as a potential opportunity requiring further exploration. Conclusions: Major gaps persist in implementing evidence-based, interdisciplinary, multicomponent nutrition care for older adults with hip fractures. A targeted implementation approach is the next step to addressing the knowledge-to-practice gap.


  • Open Access

    Structured tailored rehabilitation after hip fragility fracture: The ‘Stratify’ feasibility and pilot randomised controlled trial protocol

    by Katie J. Sheehan, Stefanny Guerra, Salma Ayis, Aicha Goubar, Nadine E. Foster, Finbarr C. Martin, Emma Godfrey, Ian D. Cameron, Celia L. Gregson, Nicola E. Walsh, et al.

    Background: Rehabilitation in hospital is effective in reducing mortality after hip fracture. However, there is uncertainty over optimal in-hospital rehabilitation treatment ingredients, and the generalizability of trial findings to subgroups of patients systematically excluded from previous trials. The aim of this study is to determine the feasibility of a randomized controlled trial which aims to assess the clinical- and cost-effectiveness of adding a stratified care intervention to usual care designed to improve outcomes of acute rehabilitation for all older adults after hip fracture. Methods: This is a protocol for a single site, feasibility and pilot, pragmatic, parallel group (allocation ratio 1:1) randomised controlled assessor-blind STRATIFY trial (Structured Tailored Rehabilitation AfTer HIp FragilitY Fracture). Adults aged 60 years or more, surgically treated for hip fracture following low energy trauma (fragility fracture), who are willing to provide consent or by consultee declaration (depending on capacity), are eligible. Individuals who experienced in-hospital hip fracture will be excluded. Screening, consent/assent, baseline assessment (demographics, patient reported outcome measures or PROMs [health related quality of life, activities of daily living, pain, falls related self-efficacy], and resource use), and randomization will take place within the first four days post-admission. Participants will then be offered usual care, or usual care plus STRATIFY intervention during their hospital stay. The STRATIFY intervention includes 1) a web-based algorithm to allocate participants to low- medium- or high-risk subgroups; and 2) matched interventions depending on subgroup allocation. The low-risk subgroup will be offered a self-management review, training in advocacy, and a self-managed exercise programme with support for progression, in addition to usual care (1-hour 40 minutes therapist time above usual care). The medium-risk subgroup will be offered education, a goal-orientated mobility programme (with carer training, as available and following carer consent), and early enhanced discharge planning, in addition to usual care (estimated 2-hours 15 minutes therapist time above usual care). The high-risk subgroup will be offered education, enhanced assessment, orientation, and a goal-orientated activities of daily living programme (with carer training, as available and following carer consent), in addition to usual care (estimated 2-hours 45minutes therapist time above usual care). All STRATIFY subgroup treatment interventions are specified using the Rehabilitation Treatment Specification System (RTSS) for treatment theory development and replication. Follow-up PROM data collection, RESOURCE USE alongside readmissions and mortality, will be collected on discharge and 12-weeks post-randomisation. Intervention acceptability will be determined by semi-structured interviews with participants, carers, and therapists at the end of the intervention. Dissemination: The trial findings will be disseminated to patients and the public, health professionals and researchers through publications, presentations and social media channels. Trial registration: The trial has been registered at clinicaltrials.gov (NCT06014554).


  • Open Access

    Protocol for a feasibility randomised controlled trial of the ‘Outdoor’ mobility intervention for older adults after hip fracture

    by Katie J. Sheehan, Denise Bastas, Stefanny Guerra, Siobhan Creanor, Claire Hulme, Sallie Lamb, Finbarr C. Martin, Catherine Sackley, Toby Smith, Philip Bell, et al.

    Background: A high proportion of patients do not regain outdoor mobility after hip fracture. Rehabilitation explicitly targeting outdoor mobility is needed to enable these older adults to recover activities which they value most. The overarching aim of this study is to determine the feasibility of a randomised controlled trial which aims to assess the clinical- and cost-effectiveness of an intervention designed to enable recovery of outdoor mobility among older adults after hip fracture (the OUTDOOR intervention). Methods: This is a protocol for a multi-centre pragmatic parallel group (allocation ratio 1:1) randomised controlled assessor-blinded feasibility trial. Adults aged 60 years or more, admitted to hospital from- and planned discharge to- home, with self-reported outdoor mobility in the three-months pre-fracture, surgically treated for hip fracture, and who are able to consent and participate, are eligible. Individuals who require two or more people to support mobility on discharge will be excluded. Screening and consent (or consent to contact) will take place in hospital. Baseline assessment and randomisation will follow discharge from hospital. Participants will then receive usual care (delivered by physiotherapy, occupational therapy, or therapy assistants), or usual care plus the OUTDOOR intervention. The OUTDOOR intervention includes a goal-orientated outdoor mobility programme (supported by up to six in-person visits), therapist-led motivational dialogue (supported by up to four telephone calls), supported by a past-patient led video where recovery experiences are shared, and support to transition to independent ongoing recovery. Therapists delivering the OUTDOOR intervention (distinct from those supporting usual care) will receive training in motivational interviewing and behaviour change techniques. Baseline demographics will be collected. Patient reported outcome measures including health related quality of life, activities of daily living, pain, community mobility, falls related self-efficacy, resource use, readmissions, and mortality will be collected at baseline, 6-weeks, 12-weeks, and 6-months (for those enrolled early in the trial) post-randomisation. Exercise adherence (6- and 12- weeks) and intervention acceptability (12-weeks) will be collected. A subset of 20 participants will also support accelerometery data collection for 10 days at each time point. Dissemination: The trial findings will be disseminated to patients and the public, health professionals and researchers through publications, presentations and social media channels. Trial registration: The trial has been registered at ISRCTN16147125. Protocol version: 3.0.